CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Curis, Inc.
Curis, Inc.
AstraZeneca
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Zhejiang DTRM Biopharma
Celgene
AO GENERIUM
Celgene
Takeda
AbbVie
Amgen Research (Munich) GmbH
LEO Pharma
Nordic Nanovector
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH
Seagen Inc.
Ariad Pharmaceuticals
Antisoma Research